BRPI0920752A2 - dispositivo implantável para a distribuição de octreotídeo e métodos de uso do mesmo - Google Patents

dispositivo implantável para a distribuição de octreotídeo e métodos de uso do mesmo

Info

Publication number
BRPI0920752A2
BRPI0920752A2 BRPI0920752A BRPI0920752A BRPI0920752A2 BR PI0920752 A2 BRPI0920752 A2 BR PI0920752A2 BR PI0920752 A BRPI0920752 A BR PI0920752A BR PI0920752 A BRPI0920752 A BR PI0920752A BR PI0920752 A2 BRPI0920752 A2 BR PI0920752A2
Authority
BR
Brazil
Prior art keywords
octreotide
distribution
methods
implantable device
implantable
Prior art date
Application number
BRPI0920752A
Other languages
English (en)
Inventor
Harry Quandt
Petr Kuzma
Original Assignee
Endo Pharmaceuticals Solutions
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Pharmaceuticals Solutions filed Critical Endo Pharmaceuticals Solutions
Publication of BRPI0920752A2 publication Critical patent/BRPI0920752A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6957Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0920752A 2008-09-30 2009-09-29 dispositivo implantável para a distribuição de octreotídeo e métodos de uso do mesmo BRPI0920752A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10155208P 2008-09-30 2008-09-30
PCT/US2009/058801 WO2010039717A1 (en) 2008-09-30 2009-09-29 Implantable device for the delivery of octreotide and methods of use thereof

Publications (1)

Publication Number Publication Date
BRPI0920752A2 true BRPI0920752A2 (pt) 2015-12-22

Family

ID=41557438

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920752A BRPI0920752A2 (pt) 2008-09-30 2009-09-29 dispositivo implantável para a distribuição de octreotídeo e métodos de uso do mesmo

Country Status (14)

Country Link
US (4) US20110244015A1 (pt)
EP (1) EP2344122A1 (pt)
JP (1) JP2012504144A (pt)
KR (1) KR20110066934A (pt)
CN (1) CN102202645A (pt)
AU (1) AU2009298711B2 (pt)
BR (1) BRPI0920752A2 (pt)
CA (1) CA2739180C (pt)
IL (1) IL211953A (pt)
MX (1) MX2011003300A (pt)
RU (1) RU2549473C2 (pt)
UA (1) UA105502C2 (pt)
WO (1) WO2010039717A1 (pt)
ZA (1) ZA201102949B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2437639C (en) 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
US7858110B2 (en) 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
CA2739180C (en) * 2008-09-30 2017-12-19 Endo Pharmaceuticals Solutions Inc. Implantable device for the delivery of octreotide and methods of use thereof
BRPI0919465A2 (pt) 2008-09-30 2015-12-01 Endo Pharmaceuticals Solutions dispositivo implantável para a liberação de risperidona e métodos de uso do mesmo
JP6149183B2 (ja) 2011-10-24 2017-06-21 ブレイバーン ファーマシューティカルズ,インコーポレイティド 移植可能チザニジン組成物及びその治療方法
WO2013063082A1 (en) * 2011-10-24 2013-05-02 Endo Pharmaceuticals Solutions Inc. Implantable rasagiline compositions and methods of treatment thereof
US20130144250A1 (en) * 2011-10-24 2013-06-06 Endo Pharmaceuticals Solutions Inc. Implantable drug delivery compositions and methods of treatment thereof
PT2968880T (pt) 2013-03-15 2025-07-07 Taris Biomedical Llc Dispositivos de aplicação de fármaco com componente permeável a fármaco
KR20170016884A (ko) * 2014-05-30 2017-02-14 텍스타일-베이스드 딜리버리, 인코포레이티드 약물 전달 시스템 및 관련 사용 방법
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법
US11820890B2 (en) 2021-04-01 2023-11-21 Stratasys Inc Pulverulent thermoplastic polymer blends

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
EP1169025B1 (en) * 1999-04-01 2005-08-24 Alza Corporation Transdermal drug delivery devices comprising a polyurethane drug reservoir
AU2003228083A1 (en) * 2002-05-23 2003-12-12 Discure, Ltd. Joint and dental implants
CA2437639C (en) * 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
WO2006078320A2 (en) * 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
CN101193626A (zh) * 2005-03-11 2008-06-04 益德威士医药股份有限公司 奥曲肽的受控释放制剂
CA2729139C (en) * 2008-06-25 2016-07-26 Endo Pharmaceuticals Solutions Inc. Octreotide implant having a release agent
CA2739180C (en) * 2008-09-30 2017-12-19 Endo Pharmaceuticals Solutions Inc. Implantable device for the delivery of octreotide and methods of use thereof

Also Published As

Publication number Publication date
IL211953A (en) 2015-11-30
MX2011003300A (es) 2011-06-09
US20190365847A1 (en) 2019-12-05
IL211953A0 (en) 2011-06-30
CA2739180C (en) 2017-12-19
US20210161994A1 (en) 2021-06-03
KR20110066934A (ko) 2011-06-17
CN102202645A (zh) 2011-09-28
UA105502C2 (uk) 2014-05-26
WO2010039717A1 (en) 2010-04-08
ZA201102949B (en) 2015-12-23
RU2011117327A (ru) 2012-11-10
US20110244015A1 (en) 2011-10-06
AU2009298711A1 (en) 2010-04-08
JP2012504144A (ja) 2012-02-16
US20150283201A1 (en) 2015-10-08
AU2009298711B2 (en) 2015-10-29
RU2549473C2 (ru) 2015-04-27
CA2739180A1 (en) 2010-04-08
EP2344122A1 (en) 2011-07-20

Similar Documents

Publication Publication Date Title
BRPI0919465A2 (pt) dispositivo implantável para a liberação de risperidona e métodos de uso do mesmo
BRPI0920752A2 (pt) dispositivo implantável para a distribuição de octreotídeo e métodos de uso do mesmo
BRPI1013432A2 (pt) derivado de indolizina e uso do mesmo para propósitos médicos
BR112012010991A2 (pt) âncoras de implante e cabelo e sistemas e métodos para seu uso
BRPI0910960A2 (pt) método para monitoramento do uso não autorizado de um dispositivo
CO6821883A2 (es) Nuevos moduladores y métodos para su uso
BRPI0908379A2 (pt) sistemas e métodos para obter dentaduras customizadas
BR112013009835A2 (pt) dispositivo para a remoção de material e método de uso
DE602008002815D1 (de) Knochenverankerungsvorrichtung
BR112013016226A2 (pt) dispositivo de sutura, método de uso de um dispositivo de sutura e material de sutura de tecido
BRPI0914034A2 (pt) dispositivo para limpeza de piso e método de limpeza de um piso
BRPI0813989A2 (pt) Dispositivo e método de retração de tecido gengival
BRPI0917141A2 (pt) implante de stent dotado de área de assentamento estendida e método para uso do mesmo
BRPI0821648A2 (pt) Método e dispositivo para pó desagregante
BRPI0914862A2 (pt) método e dispositivo para colocação de implante
BRPI0907257A8 (pt) sistemas e métodos para estimulação elétrica terapêutica
DE602008004191D1 (de) Knochenverankerungsvorrichtung
DE602007007466D1 (de) Knochenverankerungsvorrichtung
BR112012004151A2 (pt) "método e dispositivo para verificar senha dinâmica"
BRPI0915928A2 (pt) composições e métodos de uso para anticorpos terapêuticos
BRPI0918573A2 (pt) dispositivo de proteção embólica temporária e procedimento médico para sua distribuição
BRPI0816835A2 (pt) dispositivo de pulverização e método de uso do mesmo
BR112012031232A2 (pt) método, dispositivo e uso
BRPI0905983A2 (pt) Método e aparelho para calcinação de gesso pressurizado
BRPI0910763A2 (pt) métodos e dispositivos para dissecção de tecidos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]